DCF WITH SENSITIVITY ANALYSIS
1 DCF
Assumptions
Discount rate - WACC 14.00%
Long term CF growth rate 1.5%
Discounted Cash Flows 2024 2025
$ thousands
EBIT 1,492 1,502
Tax (240) (239)
Non-cash items added back 293 375
Net Working capital adjustments (164) (218)
CAPEX adjustments (750) (900)
Free Cash Flow 632 520
Discount factor 1.140 1.300
DCF 554 400
Valuation
Valuation date
Cumulated DCF 5,022
Terminal Value 31,771
Discounted Terminal Value 6,594
DCF value of operations 11,617
Excess cash and marketable securities 1,310
Excess real estate 25
Investments in nonconsolidated companies 12
Tax loss carryforwards 12
Discontinued operations 40
Non-operating assets adjustments 1,399
Enterprise value 13,016
Financial liabilities (720)
Interest bearing debt (720)
Long-term operating provisions (50)
Nonoperating provisions (75)
Contingent liabilities (40)
Debt equivalents (165)
Convertible debt (25)
Employee stock options (50)
Noncontrolling
Hybrid interests
claims and non controlling interests (150)
(225)
Equity value 11,906
2 SENSITIVITY ANALYSIS
11,906
4.00%
5.00%
6.00%
7.00%
8.00%
9.00%
WACC
10.00%
11.00%
12.00%
13.00%
14.00%
15.00%
16.00%
Check -1
2026 2027 2028 2029 2030 2031 2032
1,721 1,739 1,971 2,236 2,067 2,010 1,825
(270) (257) (306) (346) (318) (307) (278)
406 503 513 653 1,101 1,574 2,232
(136) (154) (175) (164) (183) (205) (230)
(200) (355) (135) (1,290) (2,300) (2,600) (4,900)
1,521 1,476 1,869 1,089 367 471 (1,350)
1.482 1.689 1.925 2.195 2.502 2.853 3.252
1,027 874 971 496 147 165 (415)
Download full Corporate Mod
6 Hours of video course
50+ Finance models in Excel
35 Lessons divided in 5 modules
10+ Languages course subtitles
330 Pages of instructions
30+ Pieces of actionable content
Advanced platform interface
Advanced platform interface
Long term CF growth rate
0.00% 0.50% 1.00% 1.50% 2.00% 2.50% 3.00%
2033 2034 2035
1,631 1,451 1,875
(246) (217) (294)
2,968 3,769 4,056
(257) (289) (325)
(4,400) (4,400) (1,400)
(305) 313 3,913
3.707 4.226 4.818
(82) 74 812
rporate Modeling Pack
cel
odules
btitles
content
ace
ace
3.50%